Urolithiasis and the risk of ESRD

Ziad M El-Zoghby, John C Lieske, Robert N. Foley, Eric J. Bergstralh, Xujian Li, L. Joseph Melton, Amy E. Krambeck, Andrew D Rule

Research output: Contribution to journalArticle

59 Citations (Scopus)

Abstract

Background and objectives The contribution of urolithiasis, if any, to the development of ESRD is unclear. Design, setting, participants, & measurements All stone formers in Olmsted County, Minnesota, first diagnosed between 1984 and 2008 were identified by diagnostic codes with up to four controls matched on age and sex. Charts were reviewed to validate symptomatic stone formers in a random subset. Incident ESRD events were identified by the US Renal Data System. Results Altogether, 51 stone formers and 75 controls developed ESRD among 6926 stone formers and 24,620 matched controls followed for a mean of 9 years. Stone formers had an increased risk of ESRD after adjusting for diabetes, hypertension, dyslipidemia, gout, and CKD (hazard ratio: 2.09; 95% confidence interval: 1.45-3.01). This increased risk of ESRD remained in the subset of 2457 validated symptomatic stone formers (hazard ratio: 1.95; 95% confidence interval: 1.09-3.49). The attributable risk of ESRD from symptomatic urolithiasis was 5.1% based on a prevalence of 5.4% for stone formers. For stone formers versus controls who developed ESRD, there was an increased likelihood of past hydronephrosis (44% versus 4%), recurrent urinary tract infections (26% versus 4%), acquired single kidney (15% versus 3%), neurogenic bladder (12% versus 1%), and ileal conduit (9% versus 0%), but not diabetes (32% versus 49%) or hypertension (44% versus 52%). Conclusions Symptomatic stone formers are at increased risk for ESRD independent of several cardiovascular risk factors. Other urological disease is relatively common among stone formers who develop ESRD.

Original languageEnglish (US)
Pages (from-to)1409-1415
Number of pages7
JournalClinical Journal of the American Society of Nephrology
Volume7
Issue number9
DOIs
StatePublished - Sep 1 2012

Fingerprint

Urolithiasis
Chronic Kidney Failure
Confidence Intervals
Hypertension
Kidney
Urologic Diseases
Neurogenic Urinary Bladder
Urinary Diversion
Hydronephrosis
Gout
Dyslipidemias
Information Systems
Urinary Tract Infections

ASJC Scopus subject areas

  • Nephrology
  • Transplantation
  • Epidemiology
  • Critical Care and Intensive Care Medicine

Cite this

Urolithiasis and the risk of ESRD. / El-Zoghby, Ziad M; Lieske, John C; Foley, Robert N.; Bergstralh, Eric J.; Li, Xujian; Joseph Melton, L.; Krambeck, Amy E.; Rule, Andrew D.

In: Clinical Journal of the American Society of Nephrology, Vol. 7, No. 9, 01.09.2012, p. 1409-1415.

Research output: Contribution to journalArticle

El-Zoghby, ZM, Lieske, JC, Foley, RN, Bergstralh, EJ, Li, X, Joseph Melton, L, Krambeck, AE & Rule, AD 2012, 'Urolithiasis and the risk of ESRD', Clinical Journal of the American Society of Nephrology, vol. 7, no. 9, pp. 1409-1415. https://doi.org/10.2215/CJN.03210312
El-Zoghby, Ziad M ; Lieske, John C ; Foley, Robert N. ; Bergstralh, Eric J. ; Li, Xujian ; Joseph Melton, L. ; Krambeck, Amy E. ; Rule, Andrew D. / Urolithiasis and the risk of ESRD. In: Clinical Journal of the American Society of Nephrology. 2012 ; Vol. 7, No. 9. pp. 1409-1415.
@article{7387b56b611e4cc5b6199cae8522c6fb,
title = "Urolithiasis and the risk of ESRD",
abstract = "Background and objectives The contribution of urolithiasis, if any, to the development of ESRD is unclear. Design, setting, participants, & measurements All stone formers in Olmsted County, Minnesota, first diagnosed between 1984 and 2008 were identified by diagnostic codes with up to four controls matched on age and sex. Charts were reviewed to validate symptomatic stone formers in a random subset. Incident ESRD events were identified by the US Renal Data System. Results Altogether, 51 stone formers and 75 controls developed ESRD among 6926 stone formers and 24,620 matched controls followed for a mean of 9 years. Stone formers had an increased risk of ESRD after adjusting for diabetes, hypertension, dyslipidemia, gout, and CKD (hazard ratio: 2.09; 95{\%} confidence interval: 1.45-3.01). This increased risk of ESRD remained in the subset of 2457 validated symptomatic stone formers (hazard ratio: 1.95; 95{\%} confidence interval: 1.09-3.49). The attributable risk of ESRD from symptomatic urolithiasis was 5.1{\%} based on a prevalence of 5.4{\%} for stone formers. For stone formers versus controls who developed ESRD, there was an increased likelihood of past hydronephrosis (44{\%} versus 4{\%}), recurrent urinary tract infections (26{\%} versus 4{\%}), acquired single kidney (15{\%} versus 3{\%}), neurogenic bladder (12{\%} versus 1{\%}), and ileal conduit (9{\%} versus 0{\%}), but not diabetes (32{\%} versus 49{\%}) or hypertension (44{\%} versus 52{\%}). Conclusions Symptomatic stone formers are at increased risk for ESRD independent of several cardiovascular risk factors. Other urological disease is relatively common among stone formers who develop ESRD.",
author = "El-Zoghby, {Ziad M} and Lieske, {John C} and Foley, {Robert N.} and Bergstralh, {Eric J.} and Xujian Li and {Joseph Melton}, L. and Krambeck, {Amy E.} and Rule, {Andrew D}",
year = "2012",
month = "9",
day = "1",
doi = "10.2215/CJN.03210312",
language = "English (US)",
volume = "7",
pages = "1409--1415",
journal = "Clinical Journal of the American Society of Nephrology",
issn = "1555-9041",
publisher = "American Society of Nephrology",
number = "9",

}

TY - JOUR

T1 - Urolithiasis and the risk of ESRD

AU - El-Zoghby, Ziad M

AU - Lieske, John C

AU - Foley, Robert N.

AU - Bergstralh, Eric J.

AU - Li, Xujian

AU - Joseph Melton, L.

AU - Krambeck, Amy E.

AU - Rule, Andrew D

PY - 2012/9/1

Y1 - 2012/9/1

N2 - Background and objectives The contribution of urolithiasis, if any, to the development of ESRD is unclear. Design, setting, participants, & measurements All stone formers in Olmsted County, Minnesota, first diagnosed between 1984 and 2008 were identified by diagnostic codes with up to four controls matched on age and sex. Charts were reviewed to validate symptomatic stone formers in a random subset. Incident ESRD events were identified by the US Renal Data System. Results Altogether, 51 stone formers and 75 controls developed ESRD among 6926 stone formers and 24,620 matched controls followed for a mean of 9 years. Stone formers had an increased risk of ESRD after adjusting for diabetes, hypertension, dyslipidemia, gout, and CKD (hazard ratio: 2.09; 95% confidence interval: 1.45-3.01). This increased risk of ESRD remained in the subset of 2457 validated symptomatic stone formers (hazard ratio: 1.95; 95% confidence interval: 1.09-3.49). The attributable risk of ESRD from symptomatic urolithiasis was 5.1% based on a prevalence of 5.4% for stone formers. For stone formers versus controls who developed ESRD, there was an increased likelihood of past hydronephrosis (44% versus 4%), recurrent urinary tract infections (26% versus 4%), acquired single kidney (15% versus 3%), neurogenic bladder (12% versus 1%), and ileal conduit (9% versus 0%), but not diabetes (32% versus 49%) or hypertension (44% versus 52%). Conclusions Symptomatic stone formers are at increased risk for ESRD independent of several cardiovascular risk factors. Other urological disease is relatively common among stone formers who develop ESRD.

AB - Background and objectives The contribution of urolithiasis, if any, to the development of ESRD is unclear. Design, setting, participants, & measurements All stone formers in Olmsted County, Minnesota, first diagnosed between 1984 and 2008 were identified by diagnostic codes with up to four controls matched on age and sex. Charts were reviewed to validate symptomatic stone formers in a random subset. Incident ESRD events were identified by the US Renal Data System. Results Altogether, 51 stone formers and 75 controls developed ESRD among 6926 stone formers and 24,620 matched controls followed for a mean of 9 years. Stone formers had an increased risk of ESRD after adjusting for diabetes, hypertension, dyslipidemia, gout, and CKD (hazard ratio: 2.09; 95% confidence interval: 1.45-3.01). This increased risk of ESRD remained in the subset of 2457 validated symptomatic stone formers (hazard ratio: 1.95; 95% confidence interval: 1.09-3.49). The attributable risk of ESRD from symptomatic urolithiasis was 5.1% based on a prevalence of 5.4% for stone formers. For stone formers versus controls who developed ESRD, there was an increased likelihood of past hydronephrosis (44% versus 4%), recurrent urinary tract infections (26% versus 4%), acquired single kidney (15% versus 3%), neurogenic bladder (12% versus 1%), and ileal conduit (9% versus 0%), but not diabetes (32% versus 49%) or hypertension (44% versus 52%). Conclusions Symptomatic stone formers are at increased risk for ESRD independent of several cardiovascular risk factors. Other urological disease is relatively common among stone formers who develop ESRD.

UR - http://www.scopus.com/inward/record.url?scp=84866111155&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84866111155&partnerID=8YFLogxK

U2 - 10.2215/CJN.03210312

DO - 10.2215/CJN.03210312

M3 - Article

C2 - 22745275

AN - SCOPUS:84866111155

VL - 7

SP - 1409

EP - 1415

JO - Clinical Journal of the American Society of Nephrology

JF - Clinical Journal of the American Society of Nephrology

SN - 1555-9041

IS - 9

ER -